Using machine learning to advance disparities research: Subgroup analyses of access to opioid treatment
- PMID: 34657287
- PMCID: PMC8928038
- DOI: 10.1111/1475-6773.13896
Using machine learning to advance disparities research: Subgroup analyses of access to opioid treatment
Abstract
Objective: To operationalize an intersectionality framework using a novel statistical approach and with these efforts, improve the estimation of disparities in access (i.e., wait time to treatment entry) to opioid use disorder (OUD) treatment beyond race.
Data source: Sample of 941,286 treatment episodes collected in 2015-2017 in the United States from the Treatment Episodes Data Survey (TEDS-A) and a subset from California (n = 188,637) and Maryland (n = 184,276), states with the largest sample of episodes.
Study design: This retrospective subgroup analysis used a two-step approach called virtual twins. In Step 1, we trained a classification model that gives the probability of waiting (1 day or more). In Step 2, we identified subgroups with a higher probability of differences due to race. We tested three classification models for Step 1 and identified the model with the best estimation.
Data collection: Client data were collected by states during personal interviews at admission and discharge.
Principal findings: Random forest was the most accurate model for the first step of subgroup analysis. We found large variation across states in racial disparities. Stratified analysis of two states with the largest samples showed critical factors that augmented disparities beyond race. In California, factors such as service setting, referral source, and homelessness defined the subgroup most vulnerable to racial disparities. In Maryland, service setting, prior episodes, receipt of medication-assisted opioid treatment, and primary drug use frequency augmented disparities beyond race. The identified subgroups had significantly larger racial disparities.
Conclusions: The methodology used in this study enabled a nuanced understanding of the complexities in disparities research. We found state and service factors that intersected with race and augmented disparities in wait time. Findings can help decision makers target modifiable factors that make subgroups vulnerable to waiting longer to enter treatment.
Keywords: racial disparities; regression tree; subgroup analysis; virtual twins; wait time for opioid treatment.
© 2021 The Authors. Health Services Research published by Wiley Periodicals LLC on behalf of Health Research and Educational Trust.
Figures




Similar articles
-
Use of machine learning to examine disparities in completion of substance use disorder treatment.PLoS One. 2022 Sep 23;17(9):e0275054. doi: 10.1371/journal.pone.0275054. eCollection 2022. PLoS One. 2022. PMID: 36149868 Free PMC article.
-
Race/Ethnicity and Sex and Opioid Administration in the Emergency Room.Anesth Analg. 2019 May;128(5):1005-1012. doi: 10.1213/ANE.0000000000003517. Anesth Analg. 2019. PMID: 29863607 Free PMC article.
-
Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?Drug Alcohol Depend. 2018 Sep 1;190:170-178. doi: 10.1016/j.drugalcdep.2018.06.006. Epub 2018 Jul 11. Drug Alcohol Depend. 2018. PMID: 30041092
-
Opioid Use Disorder and Racial/Ethnic Health Disparities: Prevention and Management.Curr Pain Headache Rep. 2022 Feb;26(2):129-137. doi: 10.1007/s11916-022-01010-4. Epub 2022 Feb 18. Curr Pain Headache Rep. 2022. PMID: 35179723 Review.
-
Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment.Am J Health Syst Pharm. 2010 Mar 15;67(6):462-8. doi: 10.2146/ajhp090161. Am J Health Syst Pharm. 2010. PMID: 20208053 Review.
Cited by
-
Are Treatment Services Ready for the Use of Big Data Analytics and AI in Managing Opioid Use Disorder?J Med Internet Res. 2025 Apr 28;27:e58723. doi: 10.2196/58723. J Med Internet Res. 2025. PMID: 40294410 Free PMC article.
-
Determinants of outpatient substance use disorder treatment length-of-stay and completion: the case of a treatment program in the southeast U.S.Sci Rep. 2023 Aug 26;13(1):13961. doi: 10.1038/s41598-023-41350-8. Sci Rep. 2023. PMID: 37633996 Free PMC article.
-
Use of machine learning to examine disparities in completion of substance use disorder treatment.PLoS One. 2022 Sep 23;17(9):e0275054. doi: 10.1371/journal.pone.0275054. eCollection 2022. PLoS One. 2022. PMID: 36149868 Free PMC article.
-
A Tutorial for Propensity Score Weighting for Moderation Analysis With Categorical Variables: An Application Examining Smoking Disparities Among Sexual Minority Adults.Med Care. 2023 Dec 1;61(12):836-845. doi: 10.1097/MLR.0000000000001922. Epub 2023 Oct 2. Med Care. 2023. PMID: 37782463 Free PMC article.
-
Factors predicting access to medications for opioid use disorder for housed and unhoused patients: A machine learning approach.PLoS One. 2024 Sep 27;19(9):e0308791. doi: 10.1371/journal.pone.0308791. eCollection 2024. PLoS One. 2024. PMID: 39331614 Free PMC article.
References
-
- Centers for Disease Control and Prevention, National Center for Health Statistics . National Vital Statistics System: Mortality Statistics. Atlanta, GA: U.S. Department of Health and Human Services; 2017.
-
- Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid‐ involved overdose deaths ‐ United States, 2010‐2015. Morb Mortal Wkly Rep. 2016;65:1445‐1452. - PubMed
-
- Eastwood B, Strang J, Marsden J. Effectiveness of treatment for opioid use disorder: a national, five‐year, prospective, observational study in England. Drug Alcohol Depend. 2017;176:139‐147. - PubMed